Hudson Bay Capital Management LP's Net Worth
$102 Million
Who is Hudson Bay Capital Management LP?
Hudson Bay Capital Management LP has an estimated net worth of $102 Million. This is based on reported shares across multiple companies, which include TETRALOGIC PHARMACEUTICALS Corp, Moringa Acquisition Corp, EnteroMedics Inc, CHEM RX CORP, M I Acquisitions, Inc., Stellar Acquisition III Inc., SCVX Corp., INNOVATE Corp., Longevity Acquisition Corp, Benessere Capital Acquisition Corp., Akers Biosciences, Inc., GALENA BIOPHARMA, INC., Alberton Acquisition Corp, Yunhong International, Trident Acquisitions Corp., East Stone Acquisition Corp, Jensyn Acquisition Corp., AMCI Acquisition Corp., Tenzing Acquisition Corp., 24HOLDINGS INC, Twin Ridge Capital Acquisition Corp., Greencity Acquisition Corp, Mountain Crest Acquisition Corp. IV, Alset Capital Acquisition Corp., First Light Acquisition Group, Inc., and Model Performance Acquisition Corp.
SEC CIK
Hudson Bay Capital Management LP's CIK is 0001393825
Past Insider Trading and Trends
2019 was Hudson Bay Capital Management LP's most active year for acquiring shares with 12 total transactions. Hudson Bay Capital Management LP's most active month to acquire stocks was the month of November. 2020 was Hudson Bay Capital Management LP's most active year for disposing of shares, totalling 13 transactions. Hudson Bay Capital Management LP's most active month to dispose stocks was the month of June. 2020 saw Hudson Bay Capital Management LP paying a total of $7,778,149.16 for 3,112,306 shares, this is the most they've acquired in one year. In 2020 Hudson Bay Capital Management LP cashed out on 3,593,181 shares for a total of $34,266,146.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRALOGIC PHARMACEUTICALS Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Moringa Acquisition Corp (MACA) Snapshot price: $11.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -401.27K |
$10.60 | -$4,253,472.60 |
0
|
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
EnteroMedics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -24.10% | -2.43M |
$0.97 | -$2,448,482.46 | 7.66M |
Oct 2 - Oct 5
| |||
No matching records found |
CHEM RX CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -66.10% | -1.44M |
$5.99 | -$8,608,055.11 | 737K |
Jul 22 - Jul 23
| |||
Form 4
| -0.10% | -3.00K |
$6.43 | -$19,250.00 | 2.88M |
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
M I Acquisitions, Inc. (PRTH) Snapshot price: $3.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.52% | -197.71K |
$10.60 | -$2,095,694.20 | 1.26M |
Jul 9 - Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |